{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:44:47Z","timestamp":1795088687327,"version":"4.10.2"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hematopoietic stem cell transplantation (HSCT) is a critical therapeutic intervention for hematological malignancies. However, infections remain a leading complication. Fluoroquinolones, particularly ciprofloxacin and levofloxacin, are commonly employed as prophylactic agents. This study compares their efficacy in preventing post-HSCT infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted using the Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Relevant studies comparing ciprofloxacin and levofloxacin in HSCT recipients were identified from biomedical databases. Randomized controlled trials and retrospective cohort studies were included. Data extraction encompassed patient demographics, intervention details, and infection outcomes. Meta-analyses employed RevMan software, using risk ratios (RR) and mean differences with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Five studies involving 1202 HSCT recipients (597 ciprofloxacin; 605 levofloxacin) were analyzed. Levofloxacin showed superior efficacy in reducing bloodstream infections (BSI) (RR\u2005=\u20051.61; 95% CI: [1.04, 2.49];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.03) and specifically gram-positive BSI (RR\u2005=\u20051.60; 95% CI: [1.09, 2.36];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.02). Both agents demonstrated similar effectiveness in preventing febrile neutropenia (RR\u2005=\u20050.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.96), gram-negative BSI (RR\u2005=\u20050.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.99), pneumonia (RR\u2005=\u20051.24;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.7), and all-cause mortality (RR\u2005=\u20051.05;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.7). Hospital stay duration was also comparable (mean differences\u2005=\u20050.57 days;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.4).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Levofloxacin is more effective in preventing gram-positive BSIs post-HSCT, while ciprofloxacin offers comparable outcomes in other infection-related parameters. Given its broader bacterial coverage and convenient dosing, levofloxacin may be preferred for prophylaxis. Further large-scale randomized trials are recommended to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042317","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:01:06Z","timestamp":1747083666000},"page":"e42317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: A meta-analytic comparison of ciprofloxacin and levofloxacin"],"prefix":"10.1097","volume":"104","author":[{"given":"Mohammed A. Hameed","family":"Albalawi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Taibah University, AL-Madinah AL-Munawarah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Mohammed","family":"Al-Sayaghi","sequence":"additional","affiliation":[{"name":"Department of Medical Surgical Nursing, College of Nursing, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia"},{"name":"Nursing Division, Faculty of Medicine and Health Sciences, Sana\u2019a University, Sana\u2019a, Yemen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samya Mohamed","family":"Hegazy","sequence":"additional","affiliation":[{"name":"Nursing Department, College of Applied Medical Sciences, Al Qurayat, Jouf University, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda Mubarak","family":"Merghani","sequence":"additional","affiliation":[{"name":"Mental Health and Psychiatric Nursing, Collage of Nursing, University of Hafr Albatin, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal M.","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Family & Community Medicine, Faculty of Medicine, University of Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina O.","family":"Abdelmagid","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy, University of Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Mohammed","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Nursing, Faculty of Nursing, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montaha Mohamed","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Nursing College, King Khalid University, Muhayle Aseer, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragaa Gasim","family":"Ahmed Mohmmed","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health Nursing, Faculty of Nursing, Al-Baha University, KSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Taha","family":"Omer","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Nursing, Faculty of Nursing, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5065-9626","authenticated-orcid":false,"given":"Hammad Ali","family":"Fadlalmola","sequence":"additional","affiliation":[{"name":"Department of Community Health Nursing, Nursing College, Taibah University, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah Zein","family":"Elgendi","sequence":"additional","affiliation":[{"name":"College of Applied Medical Science, Buraydah Colleges, AL-Qassim, Saudi Arabia"},{"name":"Faculty of Nursing, Kafrelsheikh University, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma.","volume":"371","author":"Palumbo","year":"2014","journal-title":"N Engl J Med"},{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","article-title":"Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.","volume":"33","author":"Collin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3062.2005.00088.x","article-title":"Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.","volume":"7","author":"Almyroudis","year":"2005","journal-title":"Transplant Infect Dis"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/320871","article-title":"Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.","volume":"33","author":"Ninin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ajic.2014.07.025","article-title":"Attributable costs of central line-associated bloodstream infections in a pediatric hematology\/oncology population.","volume":"42","author":"Wilson","year":"2014","journal-title":"Am J Infect Control"},{"key":"R6-20261023","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s10096-012-1652-4","article-title":"Catheter-related infections in pediatric patients with cancer.","volume":"31","author":"Cecinati","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States.","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Bio Blood Marrow Transplant"},{"issue":"suppl_2","key":"R8-20261023","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/ciy658","article-title":"Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with hla-identical sibling transplantation.","volume":"67","author":"Yan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an italian prospective multicenter survey.","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tid.12195","article-title":"Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients.","volume":"16","author":"Herbers","year":"2014","journal-title":"Transplant Infect Dis:"},{"key":"R11-20261023","first-page":"e13217","article-title":"Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.","volume":"22","author":"Modi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","article-title":"Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?","volume":"29","author":"Horan","year":"2011","journal-title":"J Clin Oncol"},{"key":"R13-20261023","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.","volume":"25","author":"Kuderer","year":"2007","journal-title":"J Clin Oncol"},{"key":"R14-20261023","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/161.3.381","article-title":"From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.","volume":"161","author":"Hughes","year":"1990","journal-title":"J Infect Dis"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jac\/44.5.587","article-title":"The prophylaxis of bacterial infections in neutropenic patients.","volume":"44","author":"Kerr","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R16-20261023","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20261023","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"R20-20261023","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80252-7","article-title":"The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.","volume":"29","author":"Del Favero","year":"1993","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00006454-199701000-00038","article-title":"Use of fluoroquinolones as prophylactic agents in patients with neutropenia.","volume":"16","author":"Patrick","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"12 Pt 1","key":"R22-20261023","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"key":"R23-20261023","first-page":"362","article-title":"Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.","volume":"24","author":"Owattanapanich","year":"2019","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"R24-20261023","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials.","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer med"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/clinids\/23.4.795","article-title":"Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.","volume":"23","author":"Cruciani","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.6004\/jnccn.2024.0056","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN clinical practice guidelines in oncology.","volume":"22","author":"Baden","year":"2024","journal-title":"J National Comprehensive Cancer Network"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"key":"R28-20261023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejcsup.2007.06.002","article-title":"Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients.","volume":"5","author":"Bucaneve","year":"2007","journal-title":"Eur J Cancer Suppl"},{"issue":"Suppl 2","key":"R29-20261023","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones.","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R32-20261023","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"R34-20261023","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R35-20261023","first-page":"557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"key":"R36-20261023","doi-asserted-by":"crossref","first-page":"107172","DOI":"10.1016\/j.ijid.2024.107172","article-title":"Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: a randomized trial.","volume":"147","author":"Farhan","year":"2024","journal-title":"Int j infect dis"},{"key":"R37-20261023","first-page":"1523","article-title":"Levofloxacin versus ciprofloxacin-based prophylaxis during the pre-engraftment phase in allogeneic hematopoietic stem cell transplant pediatric recipients: a single-center retrospective matched analysis.","volume":"10","author":"Servidio","year":"2021","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"R38-20261023","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00277-020-03947-1","article-title":"Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.","volume":"99","author":"Oliver","year":"2020","journal-title":"Ann Hematol"},{"key":"R39-20261023","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1078155218787286","article-title":"Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.","volume":"25","author":"Rambaran","year":"2019","journal-title":"J Oncol Pharmacy Pract"},{"key":"R40-20261023","doi-asserted-by":"crossref","first-page":"107172","DOI":"10.1111\/ctr.13145","article-title":"Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.","volume":"32","author":"Copeland","year":"2018","journal-title":"Clin Transplant"},{"key":"R41-20261023","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1002\/ajh.25236","article-title":"Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers.","volume":"93","author":"Rashidi","year":"2018","journal-title":"Am J Hematol"},{"key":"R42-20261023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0609.2005.00569.x","article-title":"Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.","volume":"76","author":"Fr\u00e8re","year":"2006","journal-title":"Eur J Haematol"},{"key":"R43-20261023","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1702822","article-title":"Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors.","volume":"27","author":"Reich","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl(0","key":"R44-20261023","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/130.Supplement.S24","article-title":"Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.","volume":"130","author":"Schimpff","year":"1974","journal-title":"J Infect Dis"},{"key":"R45-20261023","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","article-title":"Pseudomonas bacteremia. Retrospective analysis of 410 episodes.","volume":"145","author":"Bodey","year":"1985","journal-title":"Arch Intern Med"},{"key":"R46-20261023","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.ijantimicag.2023.106806","article-title":"Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.","volume":"61","author":"Trecarichi","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"R47-20261023","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/10428194.2023.2197532","article-title":"Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation.","volume":"64","author":"Akhmedov","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"R48-20261023","doi-asserted-by":"crossref","first-page":"101229","DOI":"10.1016\/j.blre.2024.101229","article-title":"\u201cAddressing the surge of infections by multidrug-resistant enterobacterales in hematopoietic cell transplantation.\u201d.","volume":"68","author":"Akhmedov","year":"2024","journal-title":"Blood Rev"},{"key":"R49-20261023","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1378\/chest.119.4.1114","article-title":"Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.","volume":"119","author":"Gotfried","year":"2001","journal-title":"Chest"},{"key":"R50-20261023","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/tid.12165","article-title":"Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.","volume":"16","author":"Srinivasan","year":"2014","journal-title":"Transplant Infect dis"},{"key":"R51-20261023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1700621","article-title":"Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation.","volume":"19","author":"Kolbe","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R52-20261023","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-012-1456-8","article-title":"Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).","volume":"91","author":"Weissinger","year":"2012","journal-title":"Ann Hematol"},{"key":"R53-20261023","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation.","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R54-20261023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.26194","article-title":"Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients.","volume":"64","author":"Wong Quiles","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R55-20261023","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/AAC.38.4.681","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.","volume":"38","author":"Kern","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R56-20261023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.40.2.503","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.","volume":"40","author":"Carratala","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R57-20261023","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000040840","article-title":"Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.","volume":"99","author":"Martino","year":"1998","journal-title":"Acta Haematol"},{"key":"R58-20261023","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/428732","article-title":"Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.","volume":"40","author":"Reuter","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:00:53Z","timestamp":1792767653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":54,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042317","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}